Clinic
Check Point Urgent Care of Crowley LLC
Check Point Urgent Care of Crowley LLC was paid $4.79M by Medicaid between Jan 2018 and Dec 2024, across 47 billing codes. Its largest line is 0202U, Oncology (prostate), multianalyte, gene expression profiling — 27% of everything it billed.
33Billing provider infoCHECK POINT URGENT CARE OF CROWLEY LLC
CROWLEY, LA 70526
CROWLEY, LA 70526
33aNPI1750822151assigned 03/17/2017
33bProvider typeUrgent Care Clinic/Center
28Total paid$4.79M
24GClaims120,724
24DCodes billed47
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Louisiana
Rank by total paid#14 of 98
Median peer was paid$694K
This provider vs. median6.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,847 | $238K | |
| 2019 | 23,046 | $875K | |
| 2020 | 31,258 | $1.26M | |
| 2021 | 24,025 | $1.20M | |
| 2022 | 17,559 | $632K | |
| 2023 | 11,566 | $442K | |
| 2024incomplete | 6,423 | $148K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 27% | 5,832 | 3,857 | $1.32M |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 23% | 4,155 | 3,402 | $1.11M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 15,013 | 12,715 | $750K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.7% | 11,796 | 9,355 | $369K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 7.3% | 4,565 | 4,045 | $350K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 3.1% | 1,826 | 1,414 | $148K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.9% | 2,845 | 2,451 | $140K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.6% | 2,906 | 2,440 | $76K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.4% | 7,513 | 5,980 | $67K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.4% | 1,067 | 940 | $66K |
| 99051 | 1.1% | 9,045 | 7,731 | $53K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 1.1% | 4,266 | 3,429 | $53K |
35 more codes
| 87581 | 1.0% | 4,305 | $49K | |
| 87486 | 1.0% | 4,755 | $48K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,515 | $40K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 543 | $37K |
| 86328 | <1% | 998 | $29K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 147 | $19K |
| 99205 | Prolong outpt/office vis | <1% | 200 | $19K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,015 | $14K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 343 | $12K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,328 | $6K |
| 86769 | <1% | 161 | $5K | |
| 87807 | <1% | 455 | $4K | |
| 81003 | <1% | 2,471 | $3K | |
| 74019 | <1% | 135 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,301 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,007 | $950.64 |
| 81025 | <1% | 196 | $773.68 | |
| 36416 | <1% | 1,209 | $703.96 | |
| 74018 | <1% | 30 | $552.45 | |
| 94760 | <1% | 1,010 | $391.52 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 14 | $337.67 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 47 | $305.75 |
| 81002 | <1% | 105 | $200.35 | |
| 87809 | <1% | 25 | $132.60 | |
| H0033 | Oral medication administration, direct observation | <1% | 33 | $75.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 33 | $35.84 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 71 | $12.81 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 30 | $11.77 |
| 99000 | <1% | 2,796 | $6.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 47 | $0.36 |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | 0% | 61 | $0.00 |
| 76140 | 0% | 30 | $0.00 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 14 | $0.00 |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | 0% | 18,391 | $0.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 74 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSADEGHI, SEYED (VP)
| Provider | Location | Paid |
|---|---|---|
| Check Point Urgent Care | New Iberia, LA | $4.12M |
| Check Point Urgent Care | Opelousas, LA | $3.15M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.